cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 48:1166-1174, doi:10.1016/j.jacc.2006.05.046 (Published online 25 August 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.05.046v1
48/6/1166    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossi, G. P.
Right arrow Articles by Pessina, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossi, G. P.
Right arrow Articles by Pessina, A. C.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH

The T–786C Endothelial Nitric Oxide Synthase Genotype Predicts Cardiovascular Mortality in High-Risk Patients

Gian Paolo Rossi, MD*,*, Giuseppe Maiolino, MD*, Mario Zanchetta, MD{dagger}, Daniele Sticchi, PhD*, Luigi Pedon, MD{dagger}, Maurizio Cesari, MD*, Domenico Montemurro, MD*, Renzo De Toni, BsD*, Silvia Zavattiero, PhD* and Achille C. Pessina, MD, PhD*

* DMCS-Internal Medicine 4
{dagger} Servizio di Emodinamica and Divisione di Cardiologia Ospedale di Cittadella, University of Padua, Padua, Italy

Manuscript received December 23, 2005; revised manuscript received April 13, 2006, accepted May 2, 2006.

* Reprint requests and correspondence: Dr. Gian Paolo Rossi, Clinica Medica 4, University Hospital, via Giustiniani, 2, 35126 Padova, Italy. (Email: gianpaolo.rossi{at}unipd.it).

OBJECTIVES: This study sought to investigate the impact of a common T–786C single-nucleotide polymorphism (SNP) in the promoter of the endothelial nitric oxide synthase (eNOS, NOS3) gene on cardiovascular (CV) death in a prospective cohort study.

BACKGROUND: The T–786C SNP eNOS gene implies a blunted endothelium-dependent vasodilation in hypertensive patients and was associated with multivessel coronary artery disease in cross-sectional studies, but it remained unsettled whether it carried prognostic information.

METHODS: In consecutive white patients of the GENICA (Genetic and Environmental Factors in Coronary Atherosclerosis) study, who underwent coronary angiography between 1999 and 2001, we determined the incidence of CV death at follow-up. The eNOS T–786C and the exon 7 G894T SNPs were determined by melting curve analysis of amplicons from allele-specific fluorescence resonance energy transfer probes. Plasma levels of nitrate/nitrite, nitrotyrosine, and myeloperoxidase were also measured. The Kaplan-Meier and Cox regression analyses were used to assess the impact of SNPs on event-free survival.

RESULTS: Complete follow-up data were obtained in 1,086 (98%) patients. After a median follow-up of 1,296 days (range 4 to 2,057 days), we observed 85 (8.2%) CV deaths. There was a significant impact of the T–786C eNOS genotype on CV death-free (p = 0.0102) survival, but no differences in CV death rates across G894T genotypes. The TT individuals, who showed a lower survival, exhibited higher plasma myeloperoxidase (p < 0.0001) and lower levels of nitrotyrosine (p < 0.0001) than CC patients.

CONCLUSIONS: The T–786C SNP in the promoter of eNOS bears independent prognostic information and is associated with changes in markers of oxidant stress in high-risk white patients referred for coronary angiography.

Abbreviations and Acronyms
  CV = cardiovascular
  CAD = coronary artery disease
  eNOS = endothelial nitric oxide synthase
  HDL = high-density lipoprotein
  LDL = low-density lipoprotein
  LVEF = left ventricular ejection fraction
  MI = myocardial infarction
  MMP = matrix metalloproteinase
  NO = nitric oxide
  RNS = reactive nitrogen species
  ROS = reactive oxygen species
  SNP = single-nucleotide polymorphism


Related Article

Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease: A Multiple-Level Biomarker Strategy
Malte Kelm
J. Am. Coll. Cardiol. 2006 48: 1175-1176. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Antoniades, D. Tousoulis, and C. Stefanadis
Effects of Endothelial Nitric Oxide Synthase Gene Polymorphisms on Oxidative Stress, Inflammatory Status, and Coronary Atherosclerosis: An Example of a Transient Phenotype
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1226 - 1226.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. E. Tanus-Santos and A. Casella-Filho
Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1225 - 1226.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. P. Rossi and M. Cesari
Reply
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1226 - 1227.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Kelm
Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease: A Multiple-Level Biomarker Strategy
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1175 - 1176.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home